TOPLINE:
Understanding the Risk of Second Primary Melanoma Among Different Racial Groups
Recent research utilizing data from the Surveillance, Epidemiology, and End Results (SEER) program reveals significant differences in the risk of second primary melanoma across various racial and ethnic groups. Notably, while White patients exhibit the highest absolute risk for developing a second primary melanoma, Black and Asian or Pacific Islander patients have a higher relative risk compared to the general population. These findings provide crucial insights into melanoma risks across diverse racial demographics and underscore the need for nuanced interpretation of melanoma studies.
METHODOLOGY:
Analyzing Over Half a Million Melanoma Cases
The study meticulously examined 546,756 individuals diagnosed with a first primary cutaneous melanoma across 17 SEER registries, covering the period from 2000 to 2019. The main focus was to identify cases where a second primary cutaneous melanoma diagnosis occurred at least two months following the initial diagnosis. By calculating standardized incidence ratios (SIRs) and excess absolute risks, researchers were able to compare the actual number of second melanomas with the expected incidences in the general population.
The racial and ethnic composition of the study population was predominantly White, accounting for 96% of cases. Other groups included Hispanic (3.1%), Asian or Pacific Islander (0.6%), Black (0.4%), and American Indian or Alaska Native (0.2%). This distribution highlights the challenges and importance of investigating melanoma risks in racially diverse populations.
TAKEAWAY:
Unveiling the Complex Risk Landscape of Melanoma
The study’s findings indicate that White patients have the highest absolute incidence rates of both first (47.67 per 100,000 people) and second (1,457.40 per 100,000 person-years) primary melanoma. In contrast, Black patients face the highest relative risk for developing a second primary melanoma, with a SIR of 264.39, as compared to the general population. Following them, Asian or Pacific Islander patients have a SIR of 196.68, while American Indian or Alaska Native and White patients have significantly lower SIRs of 48.47 and 11.63, respectively.
When considering excess second primary melanomas per 100,000 person-years, White patients topped the list with 1,332.07. Comparatively, the figures for American Indian or Alaska Native, Hispanic, Black, and Asian or Pacific Islander patients stood at 1,250.34, 944.33, 823.91, and 769.66, respectively. These statistics underscore that while relative risk appears higher among minority groups, the absolute risk is considerably greater among Whites, shedding light on the complexity of melanoma risk assessment.
IN PRACTICE:
Interpreting Melanoma Data with Care
The research findings emphasize the importance of carefully interpreting statistical analyses, particularly when they pertain to rare occurrences like second primary melanomas in minority populations. The study authors point out that previously reported relative risk measures can be misleading without the context of absolute risk figures. This analysis highlights a need for the medical community to consider both relative and absolute risks in order to accurately assess and address melanoma risks across diverse racial and ethnic communities.
In an editorial note accompanying the study, Mya L. Roberson, from the University of North Carolina at Chapel Hill, and Ivo Abraham, PhD, from the University of Arizona, stressed the importance of taking special care when analyzing minority populations. Such effort is crucial to ensure health equity and accuracy in medical research involving racially and ethnically diverse groups.
SOURCE:
A Collaborative Effort in Melanoma Research
The research was conducted under the leadership of Shoshana Zhang, BS, from Dell Medical School at The University of Texas at Austin. The study's findings were published online in JAMA Dermatology on October 9, lending a credible platform for further academic discussion and future research directions in melanoma risk assessment.
LIMITATIONS:
Challenges in Melanoma Research
Despite its significant contributions, the study acknowledges potential limitations. One such limitation is the possibility of misclassifying recurrent melanoma cases as second primary melanomas. Moreover, surveillance bias may have affected the identification and reporting of second primary melanomas. These limitations underscore the need for continued advancements in the methodology and surveillance strategies used in melanoma research to ensure accurate data interpretation.
DISCLOSURES:
Acknowledging the Contributions and Support
The researchers involved in the study did not disclose a specific funding source. However, one author acknowledged receiving grants from several prominent organizations, including the Robert Wood Johnson Foundation, the Dermatology Foundation Public Health Career Development Award, the National Institutes of Health, the American Cancer Society, and Meredith's Mission for Melanoma. These acknowledgments reflect the collaborative effort and support that underpin advancements in melanoma research.
출처 : 원문 보러가기